• National Health Investors Inc NHI.N, NHI is expected to show a rise in quarterly revenue when it reports results on February 25 for the period ending December 31 2024

• The Murfreesboro Tennessee-based company is expected to report a 4.0% increase in revenue to $82.672 million from $79.47 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data. (SAL is on Total Revenue basis)

• ​LSEG's mean analyst estimate for National Health Investors Inc is for earnings of 75 cents per share.

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell."

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for National Health Investors Inc is $77.00​, above​ its last closing price of $69.76. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

This summary was machine generated February 21 at 21:27 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)